A Multicenter Randomized Double-Blind Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients with Moderate-to-Severe Plaque Psoriasis OASIS-2 A Multicenter Randomized Double-Blind Placebo-Controlled Study Comparing the Efficacy and Safety of ...
Intervention name : LY3074828 INN of the intervention : mirikizumab Dosage And administration of the intervention : Administered subcutaneous injection Control intervention name : Secukinumab INN of the control intervention : secukinumab Dosage And administration of the control intervention : Administered subcutaneous injection Control intervention name : Placebo INN of the control intervention : - Dosage And administration of the control intervention : Administered subcutaneous injection Intervention name : LY3074828 INN of the intervention : mirikizumab Dosage And administration of the i ...
Eli Lilly Japan K.K.
NULL
complete
20
BOTH
120
Phase 3
Japan, Asia except Japan, North America, South America, Europe, Oceania